logo

Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash

By: odaily.com|2025/07/14 11:31:37

Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)

ZachXBT: Collaborates with Multiple Parties to Freeze Brazil Central Bank Service Provider Funds Involved in $5 Million Crypto Theft
Citi: The total circulating supply of stablecoins may increase to $1.6-3.7 trillion by 2030

You may also like

Share
copy

Gainers

Latest Crypto News

01:15

"The Big Short" Michael Burry Reveals Short Position on Tesla

01:15

The probability of a 25 basis point interest rate cut by the Federal Reserve in December is 87.6%.

01:15

Powell did not comment on the economy and monetary policy in his Stanford University speech

00:45

The SEC Chairman will deliver a speech tonight at the NYSE, outlining the future vision of the U.S. capital markets

00:45

U.S. FDIC Acting Chair to Propose Stablecoin Regulation Framework in December

Read more
Community
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MMbd@weex.com

VIP Servicessupport@weex.com